Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012649
Filing Date
2022-05-10
Accepted
2022-05-10 13:08:29
Documents
32
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 328314
2 form10-q_001.jpg GRAPHIC 2813
3 ex31-1.htm EX-31.1 11099
4 ex31-2.htm EX-31.2 10913
5 ex32-1.htm EX-32.1 5052
  Complete submission text file 0001493152-22-012649.txt   1509436

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vapa-20220331.xsd EX-101.SCH 11323
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vapa-20220331_cal.xml EX-101.CAL 21161
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vapa-20220331_def.xml EX-101.DEF 42687
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vapa-20220331_lab.xml EX-101.LAB 132680
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vapa-20220331_pre.xml EX-101.PRE 96279
26 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 89583
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 22908612
SIC: 2834 Pharmaceutical Preparations